← all drugs
Streptozocin Powder, For Solution
in shortage · Oncology · Snapshot: 2026-10-09
Day 1,550
of this shortage, counting from the FDA's first posting on 07/12/2022
- Manufacturers listed
- Teva Pharmaceuticals USA, Inc., ESTEVE PHARMACEUTICALS, S.A.
- Reported reason(s)
- Other
- Machine-readable
- JSON for this drug
Presentations (2)
| Presentation | Company | Availability | Updated |
|---|---|---|---|
| Zanosar, Powder, For Solution, 100 mg/1 mL (NDC 0703-4636-01) | Teva Pharmaceuticals USA, Inc. | Unavailable | 10/01/2026 |
| Zanosar, Powder, For Solution, 1 g/10 mL (NDC 68118-100-01) | ESTEVE PHARMACEUTICALS, S.A. | Available | 09/16/2026 |
History
Daily tracking of this drug began 2026-08-25 (the first day of the archive). No change to its FDA listing has been observed since.
Each daily snapshot is compared with the one before it; status changes, availability-wording revisions, and arrivals or removals are listed here. A change the FDA makes and reverses between two snapshots is not seen. Every daily record is kept in the public repository.
Not medical advice. ShortSupply republishes the FDA's drug-shortage data with history added. Talk to your pharmacist or prescriber about your situation — never change medication based on this site.